Sex differences between APPswePS1dE9 mice in A-beta accumulation and pancreatic islet function during the development of Alzheimer’s disease

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Diffusible, nonfibrillar ligands derived from Aβ _1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · see citing works

Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase

Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575 · see citing works

Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention

Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261 · see citing works

Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188 · see citing works

Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model

Refolo, L. M., Pappolla, M. A., Malester, B., LaFrancois, J. J., Bryant‐Thomas, T., Wang, R., Tint, G. S., Sambamurti, K., & Duff, K. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0304 · Cited by 1,003 · see citing works

Glucose Toxicity in β-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and the Glutathione Connection

Robertson, R. P., Harmon, J., Tran, P. O., Tanaka, Y., & Takahashi, H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.581 · Cited by 897 · see citing works

β-Cell death during progression to diabetes

Mathis, D. J., Vence, L., & Benoist, C. O. (2001) · Nature · doi:10.1038/414792a · Cited by 884 · see citing works

Rates and risk factors for dementia and Alzheimer’s disease: Results from EURODEM pooled analyses

Launer, L. J., Andersen, K., Dewey, M. E., Letenneur, L., Ott, A., Amaducci, L. A., Brayne, C., Copeland, J. R. M., Dartigues, J.-F., Kragh-Sorensen, P., et al. (1999) · Neurology · doi:10.1212/wnl.52.1.78 · Cited by 758 · see citing works

The Relationships Between Age, Sex, and the Incidence of Dementia and Alzheimer Disease

Gao, S., Hendrie, H. C., Hall, K. S., & Hui, S. L. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.9.809 · Cited by 751 · see citing works

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease

Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.017 · Cited by 744 · see citing works

Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: Link to brain reductions in acetylcholine

Rivera, E. J., Goldin, A., Fulmer, N., Tavares, R., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8304 · Cited by 723 · see citing works

Diabetes and gender

Gale, E. A. M., & Gillespie, K. M. (2001) · Diabetologia · doi:10.1007/s001250051573 · Cited by 558 · see citing works

A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

Refolo, L. M., Pappolla, M. A., LaFrancois, J. J., Malester, B., Schmidt, S. D., Thomas-Bryant, T., Tint, G. S., Wang, R., Mercken, M. H., Petanceska, S. S., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0422 · Cited by 521 · see citing works

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes

Takeda, S., Sato, N., Uchio‐Yamada, K., Sawada, K., Kunieda, T., Takeuchi, D., Kurinami, H., Shinohara, M., Rakugi, H., & Morishita, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000645107 · Cited by 506 · see citing works

Reduced IGF-1 signaling delays age-associated proteotoxicity in mice

Cohen, E., Paulsson, J. F., Blinder, P., Burstyn-Cohen, T., Du, D., Estepa, G., Adame, A., Pham, H. M., Holzenberger, M., Kelly, J. W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.014 · Cited by 488 · see citing works

Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease

Cao, D., Lu, H., Lewis, T. L., & Li, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703561200 · Cited by 336 · see citing works

Ketosis-Prone Type 2 Diabetes in Patients of Sub-Saharan African Origin

Mauvais-Jarvis, F., Sobngwi, E., Porcher, R., Riveline, J.-P., Kevorkian, J.-P., Vaisse, C., Charpentier, G., Guillausseau, P.-J., Vexiau, P., & Gautier, J.-F. (2004) · Diabetes · doi:10.2337/diabetes.53.3.645 · Cited by 294 · see citing works

Antidiabetic actions of estrogen: Insight from human and genetic mouse models

Louet, J., May, C. L., & Mauvais‐Jarvis, F. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0030-9 · Cited by 283 · see citing works

The future of Alzheimer's disease: The next 10 years

Hampel, H. J., Prvulovic, D., Teipel, S. J., Jessen, F., Luckhaus, C., Frölich, L., Riepe, M. W., Dodel, R. C., Leyhe, T., Bertram, L., et al. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.11.008 · Cited by 233 · see citing works

Estrogen-containing hormone therapy and Alzheimer’s disease risk: Understanding discrepant inferences from observational and experimental research

Henderson, V. W. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.017 · Cited by 215 · see citing works

Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway

Malaplate, C., Florent‐Béchard, S., Youssef, I., Koziel, V., Sponne, I., Kriem, B., Leininger‐Muller, B., Olivier, J. L., Oster, T., & Pillot, T. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.010 · Cited by 213 · see citing works

Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1ΔE9-deleted transgenic mice model of β-amyloidosis

Volianskis, A., Køstner, R., Mølgaard, M., Hass, S., & Jensen, M. S. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.005 · Cited by 167 · see citing works

Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer’s disease mouse models with abundant Aβ in plasma

Burgess, B. L., McIsaac, S. A., Naus, K. E., Chan, J. Y., Tansley, G., Yang, J., Miao, F., Ross, C. J., Eck, M. V., & Hayden, M. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.007 · Cited by 126 · see citing works

Antibodies against β‐amyloid reduce aβ oligomers, glycogen synthase kinase‐3β activation and τ phosphorylation in vivo and in vitro

Ma, Q., Lim, G. P., Harris‐White, M. E., Yang, F., Ambegaokar, S. S., Ubeda, O. J., Glabe, C. G., Teter, B., Frautschy, S. A., & Cole, G. M. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20734 · Cited by 126 · see citing works

17??-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality1

Contreras, J. L., Smyth, C. A., Bilbao, G., Young, C. J., Thompson, J. A., & Eckhoff, D. E. (2002) · Transplantation · doi:10.1097/00007890-200211150-00010 · Cited by 118 · see citing works

p75NTR Regulates Aβ Deposition by Increasing Aβ Production But Inhibiting Aβ Aggregation with Its Extracellular Domain

Wang, Y., Wang, X., Lu, J.-J., Li, Q., Gao, C., Liu, X.-H., Sun, Y., Yang, M., Lim, Y. P., Evin, G. M., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2733-10.2011 · Cited by 99 · see citing works

Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: Involvement of oxidative stress and cholinergic dysfunction

Zhang, W., Bai, M., Ye, X., Hao, J., Liu, L., Mao, N., Su, C., Miao, J., & Li, Z. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.023 · Cited by 94 · see citing works

Amyloid-β Induces Hepatic Insulin Resistance by Activating JAK2/STAT3/SOCS-1 Signaling Pathway

Zhang, Y., Zhou, B. Z., Zhang, F., Wu, J., Hu, Y., Liu, Y., & Zhai, Q. (2012) · Diabetes · doi:10.2337/db11-0499 · Cited by 93 · see citing works

Increased Aβ production prompts the onset of glucose intolerance and insulin resistance

Jiménez-Palomares, M., Ramos‐Rodríguez, J. J., López-Acosta, J. F., Pacheco‐Herrero, M., Lechuga-Sancho, A. M., Perdomo, G., Garcı́a-Alloza, M., & Cózar‐Castellano, I. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00500.2011 · Cited by 89 · see citing works

Dysregulation of brain olfactory and taste receptors in AD, PSP and CJD, and AD-related model

Ansoleaga, B., Garcia‐Esparcia, P., Llorens, F., Moreno, J., Aso, E., & Ferrer, I. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.06.034 · Cited by 84 · see citing works

Amyloid-β Induces Hepatic Insulin Resistance In Vivo via JAK2

Zhang, Y., Zhou, B. Z., Deng, B., Zhang, F., Wu, J., Wang, Y., Le, Y., & Zhai, Q. (2012) · Diabetes · doi:10.2337/db12-0670 · Cited by 81 · see citing works

Targeting Insulin Signaling for the Treatment of Alzheimer's Disease

Chen, Y., Zhang, J., Zhang, B., & Gong, C. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150813142423 · Cited by 59 · see citing works

Egr1 Expression Is Induced Following Glatiramer Acetate Immunotherapy in Rodent Models of Glaucoma and Alzheimer's Disease

Bakalash, S., Pham, M. D., Koronyo, Y., Salumbides, B. C., Kramerov, A. A., Seidenberg, H., Berel, D., Black, K. L., & Koronyo‐Hamaoui, M. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7498 · Cited by 44 · see citing works

Over expression of amyloid beta-protein reduces the number of neurons in the striatum of APPswe/PS1ΔE9

Richner, M., Bach, G., & West, M. J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.02.025 · Cited by 20 · see citing works

Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease

Camboni, M., Wang, C.-M., Miranda, C. J., Yoon, J. H., Xu, R., Zygmunt, D. A., Kaspar, B. K., & Martin, P. T. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.001 · Cited by 9 · see citing works

Mechanisms of sex differences in Alzheimer’s disease

Lopez-Lee, C., Torres, E. R. S., Carling, G., & Gan, L. (2024) · Neuron · doi:10.1016/j.neuron.2024.01.024 · Cited by 376 · see citing works

Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer’s disease during lifespan

Bäuerl, C., Collado, M. C., Diaz Cuevas, A., Viña, J., & Pérez Martínez, G. (2018) · Letters in Applied Microbiology · doi:10.1111/lam.12882 · Cited by 238 · see citing works

Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis

Mahan, T. E., Wang, C., Bao, X., Choudhury, A., Ulrich, J. D., & Holtzman, D. M. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00516-0 · Cited by 134 · see citing works

Age‐related deterioration of motor function in male and female 5xFAD mice from 3 to 16 months of age

O’Leary, T. P., Mantolino, H. M., Stover, K. R., & Brown, R. E. (2018) · Genes Brain & Behavior · doi:10.1111/gbb.12538 · Cited by 88 · see citing works

Sex differences in the IntelliCage and the Morris water maze in the APP/PS1 mouse model of amyloidosis

Mifflin, M. A., Winslow, W., Surendra, L., Tallino, S., Vural, A. S., & Velázquez, R. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.018 · Cited by 87 · see citing works

Sex and Gender Differences in Alzheimer’s Disease: Genetic, Hormonal, and Inflammation Impacts

Kolahchi, Z., Henkel, N., Eladawi, M. A., Villarreal, E. C., Kandimalla, P., Lundh, A., McCullumsmith, R. E., & Cuevas, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158485 · Cited by 63 · see citing works

Sex-specific hippocampal metabolic signatures at the onset of systemic inflammation with lipopolysaccharide in the APPswe/PS1dE9 mouse model of Alzheimer’s disease

Agostini, A., Ding, Y., Bai, L., Kendall, D. A., & Pardon, M. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.09.019 · Cited by 41 · see citing works

Liver Bile Acid Changes in Mouse Models of Alzheimer’s Disease

Kaur, H., Seeger, D. R., Golovko, S. A., Golovko, M. Y., & Combs, C. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147451 · Cited by 36 · see citing works

The APMAP interactome reveals new modulators of APP processing and beta-amyloid production that are altered in Alzheimer’s disease

Gerber, H., Mosser, S., Boury‐Jamot, B., Stumpe, M., Piersigilli, A., Goepfert, C., Dengjel, J., Albrecht, U., Magara, F., & Fraering, P. C. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0660-3 · Cited by 36 · see citing works

Chronic sleep deprivation exacerbates cognitive and synaptic plasticity impairments in APP/PS1 transgenic mice

Wang, C., Gao, W.-R., Yin, J., Wang, Z.-J., Qi, J., Cai, H.-Y., & Wu, M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113400 · Cited by 35 · see citing works

Systematic review of brain and blood lipidomics in Alzheimer's disease mouse models

Ferré‐González, L., Lloret, A., & Cháfer‐Pericás, C. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101223 · Cited by 29 · see citing works

Females exhibit higher GluA2 levels and outperform males in active place avoidance despite increased amyloid plaques in TgF344-Alzheimer's rats

Chaudry, O., Ndukwe, K., Xie, L., Figueiredo-Pereira, M., Serrano, P., & Rockwell, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-23801-w · Cited by 28 · see citing works

Akt activation ameliorates deficits in hippocampal-dependent memory and activity-dependent synaptic protein synthesis in an Alzheimer’s disease mouse model

Kommaddi, R. P., Gowaikar, R., Haseena, P. A., Diwakar, L., Singh, K. P., & Mondal, A. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105619 · Cited by 29 · see citing works

Centella asiatica Alters Metabolic Pathways Associated With Alzheimer’s Disease in the 5xFAD Mouse Model of ß-Amyloid Accumulation

Speers, A. B., García‐Jaramillo, M., Feryn, A. B., Matthews, D. G., Lichtenberg, T., Caruso, M. A., Wright, K. M., Quinn, J. F., Stevens, J. F., Maier, C. S., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.788312 · Cited by 26 · see citing works

Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer’s disease

Abdulhameed, N., Babin, A., Hansen, K. M., Weaver, R. R., Banks, W. A., Talbot, K., & Rhea, E. M. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01537-1 · Cited by 23 · see citing works

Reduction in GABAB on glia induce Alzheimer’s disease related changes

Osse, A. M. L., Pandey, R. S., Wirt, R. A., Ortiz, A. A., Salazar, A., Kimmich, M. J., Strom, E. N. T., Oblak, A. L., Lamb, B. T., Hyman, J. M., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.002 · Cited by 19 · see citing works

APOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice

Balu, D., Valencia‐Olvera, A. C., Islam, Z., Mielczarek, C., Hansen, A. L., Ramos, T. M. P., York, J. M., LaDu, M. J., & Tai, L. M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1279343 · Cited by 19 · see citing works

Aging, sex, metabolic and life experience factors: Contributions to neuro-inflammaging in Alzheimer’s disease research

Singhaarachchi, P. H., Antal, P., Calon, F., Culmsee, C., Delpech, J.-C., Feldotto, M., Geertsema, J., Hoeksema, E. E., Kőrösi, A., Layé, S., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105724 · Cited by 18 · see citing works

Interleukin-17 Promotes the Infiltration of CD8+ T Cells into the Brain in a Mouse Model for Alzheimer’s Disease

Ye, X., Chen, J., Pan, J., Wu, Q., Wang, Y., Lu, M., Zhang, C., Zhang, Z., Ma, M., Zhu, J., et al. (2022) · Immunological Investigations · doi:10.1080/08820139.2022.2136525 · Cited by 17 · see citing works

Microglial-associated responses to comorbid amyloid pathology and hyperhomocysteinemia in an aged knock-in mouse model of Alzheimer’s disease

Braun, D. J., Dimayuga, E. R., Morganti, J. M., & Eldik, L. J. V. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01938-7 · Cited by 16 · see citing works

The protective PLCγ2-P522R variant mitigates Alzheimer’s disease-associated pathologies by enhancing beneficial microglial functions

Takalo, M., Jeskanen, H., Rolova, T., Kervinen, I., Hellén, M., Heikkinen, S., Koivisto, H., Jokivarsi, K., Müller, S. A., Koivumäki, E.-M., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03387-6 · Cited by 15 · see citing works

The hibernation-derived compound SUL-138 shifts the mitochondrial proteome towards fatty acid metabolism and prevents cognitive decline and amyloid plaque formation in an Alzheimer’s disease mouse model

Mestdagh, C. F. D. V., Koopmans, F., Breiter, J. C., Timmerman, J. A., Vogelaar, P. C., Krenning, G., Mansvelder, H. D., Smit, A. B., Henning, R. H., & van Kesteren, R. E. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01127-z · Cited by 15 · see citing works

Immune-mediated platelet depletion augments Alzheimer’s disease neuropathological hallmarks in APP-PS1 mice

de Sousa, D. M. B., Benedetti, A., Altendorfer, B., Mrowetz, H., Unger, M. S., Schallmoser, K., Aigner, L., & Kniewallner, K. M. (2023) · Aging · doi:10.18632/aging.204502 · Cited by 15 · see citing works

AAV mediated carboxyl terminus of Hsp70 interacting protein overexpression mitigates the cognitive and pathological phenotypes of APP/PS1 mice

Hu, Z., Yang, J., Zhang, S., Li, M., Zuo, C., Mao, C., Zhang, Z., Tang, M., Shi, C., & Xu, Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01277 · Cited by 15 · see citing works

Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice

Koulousakis, P., Willems, E., Schepers, M., Rombaut, B., Prickaerts, J., Vanmierlo, T., & van den Hove, D. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230657 · Cited by 14 · see citing works

Gender Differences of NLRP1 Inflammasome in Mouse Model of Alzheimer's Disease

Zhang, J.-H., Pei, L.-H., Zang, D., Xue, Y., Wang, X.-H., Chen, Y.-Y., Li, J., Yu, J., Gao, Q.-Z., Di, W., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.512097 · Cited by 15 · see citing works

Inhaled xenon modulates microglia and ameliorates disease in mouse models of amyloidosis and tauopathy

Brandão, W. N., Jain, N., Yin, Z., Kleemann, K. L., Carpenter, M., Bao, X., Serrano, J. R., Tycksen, E., Durão, A. C. C. D. S., Barry, J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adk3690 · Cited by 13 · see citing works

The Ethyl Acetate Extract of Leaves of Ugni molinae Turcz. Improves Neuropathological Hallmarks of Alzheimer’s Disease in Female APPswe/PS1dE9 Mice Fed with a High Fat Diet

Jara-Moreno, D., Castro-Torres, R. D., Ettcheto, M., Auladell, C., Kogan, M. J., Folch, J., Verdaguer, E., Cano, A. C., Busquets, O., Delporte, C. L., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180174 · Cited by 12 · see citing works

TSPO contributes to neuropathology and cognitive deficits in Alzheimer’s disease

Ceyzériat, K., Badina, A. M., Abjean, L., Meyer, L., Bouteldja, F., Bałkota, M., Amossé, Q., Prudhomme, O., Middleton, R. J., Liu, G.-J., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03583-4 · Cited by 12 · see citing works

Pre-symptomatic synaptic dysfunction and longitudinal decay of hippocampal synaptic function in APPPS1 mouse model of Alzheimer’s disease is sex-independent

Sha, S., Chaigneau, T., & Krantic, S. M. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.04.005 · Cited by 10 · see citing works

The Histone H3 K4me3, K27me3, and K27ac Genome-Wide Distributions Are Differently Influenced by Sex in Brain Cortexes and Gastrocnemius of the Alzheimer’s Disease PSAPP Mouse Model

Casciaro, F., Persico, G., Rusin, M., Amatori, S., Montgomery, C. B., Rutkowsky, J. M., Ramsey, J. J., Cortopassi, G. A., Fanelli, M., & Giorgio, M. (2021) · Epigenomes · doi:10.3390/epigenomes5040026 · Cited by 9 · see citing works

Huntingtin-associated protein 1 plays an essential role in the pathogenesis of type 2 diabetes by regulating the translocation of GLUT4 in mouse adipocytes

Gong, Y., Feng, Y., Cao, Y., Jia, Z., Wu, W., Zheng, Y., Wu, J., Li, X., Yang, G., & Zhou, X. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001199 · Cited by 9 · see citing works

Knockdown of microglial iron import gene, Slc11a2, worsens cognitive function and alters microglial transcriptional landscape in a sex-specific manner in the APP/PS1 model of Alzheimer’s disease

Volk, K. M., Rodriguez, A. S., Cartailler, J., Shrestha, S., Schleh, M. W., Schroeder, K. R., Valenti, A. M., Kramer, A. T., Harrison, F. E., & Hasty, A. H. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03238-w · Cited by 8 · see citing works

(D-Ser2) oxyntomodulin recovers hippocampal synaptic structure and theta rhythm in Alzheimer’s disease transgenic mice

Qi, J., Wang, Z.-J., Yang, G., Gao, Q.-C., Li, W.-R., Cai, H.-Y., Zhao, H., Wang, J.-J., Zhao, X., Wang, J.-X., et al. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335168 · Cited by 6 · see citing works

Parishin A ameliorates cognitive decline by promoting PS1 autophagy in Alzheimer’s disease

Guo, S., Yi, L., Luo, M., Dong, Z., & Du, Y. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1516190 · Cited by 5 · see citing works

Exploring Iron Deposition Patterns Using Light and Electron Microscopy in the Mouse Brain Across Aging and Alzheimer's Disease Pathology Conditions

Lau, V. Z., VanderZwaag, J., Murray, C. J., & Tremblay, M. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70086 · Cited by 5 · see citing works

Impaired hippocampal circuit function underlying memory encoding and consolidation precede robust Aβ deposition in a mouse model of alzheimer’s disease

Li, H., Zhao, Z., Fassini, A., Lee, H. K., Green, R. J., & Gomperts, S. N. (2025) · Scientific Reports · doi:10.1038/s41598-025-05653-2 · Cited by 5 · see citing works

Sex differences in luteinizing hormone aggravates Aβ deposition in APP/PS1 and Aβ1-42-induced mouse models of Alzheimer's disease

Jia, Y., Du, X., Wang, Y., Song, Q., & He, L. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176485 · Cited by 5 · see citing works

Adult-Onset Deficiency of Mitochondrial Complex III in a Mouse Model of Alzheimer’s Disease Decreases Amyloid Beta Plaque Formation

Pinto, M., Díaz, F., Nissanka, N., Guastucci, C. S., Illiano, P., Brambilla, R., & Moraes, C. T. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02992-3 · Cited by 5 · see citing works

Combination treatment with medium dose THC and CBD had no therapeutic effect in a transgenic mouse model for Alzheimer's disease but affected other domains including anxiety-related behaviours and object recognition memory

Aumer, B., Porto, R. R., Coles, M., Ulmer, N., Watt, G., Kielstein, H., & Karl, T. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174101 · Cited by 5 · see citing works

Traumatic brain injury exacerbates mitochondrial dysfunction in APP/PS1 knock-in mice through time-dependent pathways

Moallem, E. Z., Vekaria, H. J., Macheda, T., Hawkins, M. R., Roberts, K. N., Patel, S. P., Sullivan, P. G., & Bachstetter, A. D. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115629 · Cited by 3 · see citing works

Age and sex dependent hippocampal neuronal hyperactivity in Alzheimer model mice

Hegnet, E., Häkli, S., Koivisto, H., Miettinen, P. O., Jin, N., Gureviciene, I., & Tanila, H. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115632 · Cited by 3 · see citing works

The impact of sex on memory during aging and Alzheimer's disease progression: Epigenetic mechanisms

Scheinman, S. B., & Dong, H. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241288709 · Cited by 3 · see citing works

Sex-Specific Adaptations in Alzheimer’s Disease and Ischemic Stroke: A Longitudinal Study in Male and Female APPswe/PS1dE9 Mice

Lohkamp, K. J., Timmer, N., Guardia, G. S., Shenk, J. C., Verweij, V. G. M., Geenen, B., Dederen, P. J. W. C., Bakker, L., Egitimci, C., Yoldas, R., et al. (2025) · Life · doi:10.3390/life15030333 · Cited by 4 · see citing works

Amino Acid Compound 2 (AAC2) Treatment Counteracts Insulin-Induced Synaptic Gene Expression and Seizure-Related Mortality in a Mouse Model of Alzheimer’s Disease

Deng, Z., Lee, A., Lin, T., Taneja, S., Kowdley, D., Leung, J. H., Hill, M., Tao, T., Fitzgerald, J., Yu, L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111689 · Cited by 2 · see citing works

Females outperform males in spatial learning despite increased amyloid plaques and microgliosis in a TgF344-AD rat model of Alzheimer’s diseasePreprint

Chaudry, O., Ndukwe, K., Xie, L., Serrano, P. A., Figueiredo‐Pereira, M. E., & Rockwell, P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.27.485975 · Cited by 2 · see citing works

Therapeutic efficacy of synthetic analogues of gut hormones in a mouse model of Alzheimer’s disease

Denver, P., Duffy, A. M., Kennedy, R. T., Gault, V. A., & McClean, P. L. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.01.038 · Cited by 1 · see citing works

Sex differences in Alzheimer’s disease animal models

Ippati, S., Ittner, L. M., & Ke, Y. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819344-0.00003-x · Cited by 1 · see citing works

Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach

Liu, Z., McCutcheon, F. M., Ho, H., Chia, J. S. M., Xiao, Y., Tippett, I., Keragala, C. B., CLOUD, G. C., & Medcalf, R. L. (2023) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2023.102166 · Cited by 1 · see citing works

Mild deficiency of mitochondrial Complex III in a mouse model of Alzheimer’s disease decreases amyloid beta plaque formationPreprint

Pinto, M., Díaz, F., Nissanka, N., Guastucci, C. S., Illiano, P., Brambilla, R., & Moraes, C. T. (2021) · Research Square · doi:10.21203/rs.3.rs-500142/v1

Hugging it out

Koulousakis, P. (2024) · doi:10.26481/dis.20240523pk

Additional file 1 of Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer’s disease

Abdulhameed, N., Babin, A., Hansen, K., Weaver, R. R., Banks, W. A., Talbot, K., & Rhea, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26420326

Additional file 3 of Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer’s disease

Abdulhameed, N., Babin, A., Hansen, K., Weaver, R. R., Banks, W. A., Talbot, K., & Rhea, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26756596

Additional file 2 of Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer’s disease

Abdulhameed, N., Babin, A., Hansen, K., Weaver, R. R., Banks, W. A., Talbot, K., & Rhea, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26420552

Additional file 24 of The hibernation-derived compound SUL-138 shifts the mitochondrial proteome towards fatty acid metabolism and prevents cognitive decline and amyloid plaque formation in an Alzheimer’s disease mouse model

Mestdagh, C. F. D. V., Koopmans, F., Breiter, J. C., Timmerman, J. A., Vogelaar, P. C., Krenning, G., Mansvelder, H. D., Smit, A. B., Henning, R. H., & van Kesteren, R. E. (2023) · Figshare · doi:10.6084/m9.figshare.22611868

Decreased Length of Locus Coeruleus Norepinephrine Axons and Increased Amyloid Beta Pathology in Male APP/PS1 Mice During Protracted Abstinence From Alcohol

Garland, I. J. Z., Engel, S., Scalf, M., Payne, N. R., Lee, A. M., & Graves, S. M. (2026) · Neurotoxicity Research · doi:10.1007/s12640-026-00794-2

Implication de nouvelles cibles microgliales, Cst7 et Clec7a/Dectin-1, dans le développement et la progression de la maladie d'Alzheimer

Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f

Circadian disruption induces sex-specific Alzheimer’s pathophysiology and immune cell reprogrammingPreprint

Cordi, C. V., Falkenberg, N. G., Clark, G. T., Allen, N. G., Chuah, J., Ulbrich, R., Herzog, A. A., Lanka, M., Collins, E. J., Bentley, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.30.721994

Pharmacokinetic properties of the clinical drug candidate PRI-002 with regard to genotype, sex, age, dose-dependence and food effects in mice

Camargo, L. C., Jonas, A., Gering, I., Schemmert, S., Jacobs, D., Schäfer, M., Willbold, D., Willuweit, A., & Kutzsche, J. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107649

Sex dimorphism profile of Alzheimer’s disease-type pathologies in an APP/PS1 mouse model

Jiao, S.-S., Bu, X.-L., Liu, Y.-H., Zhu, C., Wang, Q.-H., Shen, L.-L., Liu, C.-H., Wang, Y.-R., Yao, X.-Q., & Wang, Y.-J. (2016) · Neurotoxicity Research · doi:10.1007/s12640-015-9589-x · Cited by 129 · see citing works

Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice

Wang, J., Tanila, H., Puoliväli, J., Kadish, I., & Groen, T. V. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.009 · Cited by 316 · see citing works

Alzheimer’s disease‐related sex differences in insulin sensitivity, glucose metabolism, and spatial memory

Findley, C. A., Sime, L. N., McFadden, S., Hascup, K. N., Bartke, A., & Hascup, E. R. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.043146

Sex-specific hypothalamic neuropathology and glucose metabolism in an amyloidosis transgenic mouse model of Alzheimer’s disease

Qi, G., Tang, H., Gong, P., Liu, Y., He, C., Hu, J., Kang, S., Chen, L., & Qin, S. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01295-5 · Cited by 9 · see citing works

Males vs females: differences in the AB accumulation

Ordóñez‐Gutiérrez, L., Fernández, I. L., Antón, M., & Wandosell, F. G. (2015) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.13039/100008054